Peter Seidenberg, MD
Sports Medicine · Shreveport, LANPI 1114960432
Payments from drug & device makers
Across 14 payments — averaging $26.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$131
- Dexcom, Inc.$110
- Innovation Technologies Inc$47
- Pacira Pharmaceuticals Incorporated$18
- Midsouth Orthopedics Inc.$18
- Dynavax Technologies Corporation$18
- plus $30 from 2 others
What the payments were for
- Food & beverage$372100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 2 | $131 |
| Dexcom, Inc. | 5 | $110 |
| Innovation Technologies Inc | 2 | $47 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Midsouth Orthopedics Inc. | 1 | $18 |
| Dynavax Technologies Corporation | 1 | $18 |
| Pfizer | 1 | $16 |
| Bioventus LLC | 1 | $14 |
How this compares
$372 in reported general payments places this provider in the 20th percentile of 82 sports medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 40 | $47,799 |
| FarxigaDapagliflozin Propanediol | 16 | $21,573 |
| TrulicityDulaglutide | 16 | $18,695 |
| EntrestoSacubitril/Valsartan | 15 | $17,704 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $3,229 |
| Hydroxyzine Hcl | 24 | $716 |
| Atorvastatin Calcium | 60 | $478 |
| Nifedipine ErNifedipine | 17 | $356 |
| Gabapentin | 24 | $342 |
| Fluticasone Propionate | 16 | $280 |
| Losartan Potassium | 26 | $224 |
| Rosuvastatin Calcium | 24 | $224 |
| Amlodipine Besylate | 50 | $191 |
| Diclofenac Sodium | 13 | $172 |
| Chlorthalidone | 14 | $164 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Shreveport
- Mario Lobao GoncalvesShreveport$32K
- Kyle PlanchardShreveport$29K
- George ByramShreveport$14K
- Richard BartonShreveport$9K
- Carlton HoutzShreveport$3K
- Naina Bouchereau-LalShreveport$1K
- Charles WebbShreveport$980
- Felix SavoieNew Orleans$1.4M
- Misty SuriNew Orleans$1.2M
- Michael ObrienNew Orleans$396K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.